| 04.10 11:24 | EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 04.10 11:24 | EQS-PVR: Merck KGaA: Release according to Article -2- |
| 04.10 11:24 | EQS-PVR: Merck KGaA: Release according to Article -3- |
| 04.10 11:24 | EQS-PVR: Merck KGaA: Release according to Article -4- |
| 04.10 11:23 | EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution |
| 04.10 11:23 | EQS-PVR: Merck KGaA: Release according to Article -2- |
| 04.10 11:23 | EQS-PVR: Merck KGaA: Release according to Article -3- |
| 04.10 11:23 | EQS-PVR: Merck KGaA: Release according to Article -4- |
| 04.10 11:23 | dpa-AFX: EQS-Stimmrechte: Merck KGaA (english) |
| 04.10 11:23 | dpa-AFX: EQS-Public Voting Rights: Merck KGaA (english) |
| 04.10 06:22 | dpa-AFX: ANALYSE-FLASH: Jefferies belässt Merck KGaA auf 'Buy' - Ziel 180 Euro |
| 04.10 06:22 | dpa-AFX: Jefferies belässt Merck KGaA auf 'Buy' - Ziel 180 Euro |
| 24.09 09:30 | dpa-AFX: HINTERGRUND/'Fertility Benefits': Kinderwunsch mit Firmengeldern erfüllen? |
| 20.09 10:37 | dpa-AFX: AKTIEN-FLASH: Merck KGaA unter Druck - BofA skeptischer für Life-Science |
| 20.09 10:16 | dpa-AFX: *MERCK KGAA RINGEN UM EXP 200-TAGE-LINIE - BOFA KAPPT LIFE-SCIENCE-PROGNOSEN |
| 20.09 10:13 | dpa-AFX: *BOFA CUTS MERCK KGAA PRICE TARGET TO 190 (200) EUR - 'BUY' |
| 20.09 10:13 | dpa-AFX: *BOFA SENKT ZIEL FÜR MERCK KGAA AUF 190 (200) EUR - 'BUY' |
| 19.09 10:35 | dpa-AFX: ANALYSE-FLASH: Goldman startet Merck KGaA mit 'Buy' - Ziel 205 Euro |
| 19.09 10:35 | ANALYSE-FLASH: Goldman startet Merck KGaA mit 'Buy' - Ziel 205 Euro |
| 19.09 09:10 | dpa-AFX: *MERCK KGAA MIT +2,9% AN 21-TAGE-LINIE ERHOLT |
|
|
